| DSGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DSGN market cap history going back to 4/30/2021:
Also see: DSGN Shares Outstanding History and DSGN YTD Return |
As of 7/29/2026 Design Therapeutics has a market cap of 752.23 million. Investors often follow the DSGN market cap history to compare the size of the company over time.
This page shows DSGN market capitalization trends over time, with 22 market cap datapoints presented, dating back to 4/30/2021.

| DSGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DSGN market cap history going back to 4/30/2021:
Also see: DSGN Shares Outstanding History and DSGN YTD Return |
| DSGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
DSGN Historical Market Cap: -11.85% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| DSGN Stock Price Chart |
| About Design Therapeutics Inc |
| Design Therapeutics, Inc. is a biotechnology company. It is engaged in the research and development of GeneTACT molecules, which are small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its Friedreich ataxia (FA) program is focused on the development of a disease-modifying treatment. Its DT-216 is developed to overcome the FXN transcription impairment that causes FA. DT-216 is in Phase I clinical trial. We show 22 historical shares outstanding datapoints in our DSGN shares outstanding history coverage, used to compute DSGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DSGN market cap history over the course of time is important for investors interested in comparing DSGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DSGN versus a peer is one thing; comparing DSGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DSGN can fluctuate over the course of history. With this page we aim to empower investors researching DSGN by allowing them to research the DSGN market cap history. |
| DSGN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| DSGN Share Performance |
| Market Cap Peers |
| Design Therapeutics (DSGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DTIL Market Cap History DVA Market Cap History DVAX Market Cap History DVCR Market Cap History DWTX Market Cap History DXCM Market Cap History DYAI Market Cap History DYN Market Cap History DYNT Market Cap History EAR Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.